Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancer Immunology, Immunotherapy ; 70 (2020), 5. - S. 1263-1275. - ISSN 0340-7004. - eISSN 1432-0851
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2020
- Creator
-
Thaiss, Wolfgang Maximilian
Gatidis, Sergios
Sartorius, Tina
Machann, Jürgen
Peter, Andreas
Eigentler, Thomas K.
Nikolaou, Konstantin
Pichler, Bernd J.
Kneilling, Manfred
- DOI
-
10.18725/OPARU-51064
- URN
-
urn:nbn:de:bsz:289-oparu-51140-9
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Thaiss, Wolfgang Maximilian
- Gatidis, Sergios
- Sartorius, Tina
- Machann, Jürgen
- Peter, Andreas
- Eigentler, Thomas K.
- Nikolaou, Konstantin
- Pichler, Bernd J.
- Kneilling, Manfred
- Universität Ulm
Time of origin
- 2020
Other Objects (12)
Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients
Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients
Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients
Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma